ID HEC-6 AC CVCL_2931 SY HEC6 DR ArrayExpress; E-MTAB-2770 DR BioGRID_ORCS_Cell_line; 716 DR BioSample; SAMN03470939 DR BioSample; SAMN03472457 DR BioSample; SAMN10987852 DR cancercelllines; CVCL_2931 DR Cell_Model_Passport; SIDM01619 DR Cosmic; 1223490 DR Cosmic; 1696749 DR Cosmic; 2030473 DR DepMap; ACH-000984 DR GEO; GSM887075 DR GEO; GSM888145 DR IARC_TP53; 21068 DR IARC_TP53; 30207 DR JCRB; JCRB1118 DR JCRB; NIHS0390 DR LiGeA; CCLE_478 DR PharmacoDB; HEC6_531_2019 DR Progenetix; CVCL_2931 DR Wikidata; Q54882266 RX DOI=10.1007/978-4-431-53981-0_1; RX PubMed=862644; RX PubMed=2064198; RX PubMed=10381137; RX PubMed=15053063; RX PubMed=22460905; RX PubMed=25877200; RX PubMed=26589293; RX PubMed=28196595; RX PubMed=30894373; RX PubMed=31068700; RX PubMed=31978347; WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: MD Anderson Cell Lines Project. CC Population: Japanese. CC Doubling time: 52 hours (PubMed=862644). CC HLA typing: A*24:02,24:02; B*59:01,59:01; C*01:02,01:02; DQA1*05:02,05:02; DQB1*04:01,04:01; DRB1*04:05,11:04 (PubMed=26589293). CC Microsatellite instability: Instable (MSI) (PubMed=31068700). CC Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Val (c.95A>T); ClinVar=VCV000376230; Zygosity=Heterozygous (DepMap=ACH-000984). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Val160Ala (c.479T>C); Zygosity=Heterozygous (DepMap=ACH-000984). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000280875; Zygosity=Heterozygous (DepMap=ACH-000984). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420_Pro421del (c.1258_1263delTGTCCA); Zygosity=Heterozygous (DepMap=ACH-000984). CC Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (DepMap=ACH-000984). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (DepMap=ACH-000984). CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0%; Native American=0%; East Asian, North=75.17%; East Asian, South=23.89%; South Asian=0%; European, North=0%; European, South=0.94% (PubMed=30894373). CC Discontinued: JCRB; NIHS0390; true. CC Derived from site: In situ; Endometrium; UBERON=UBERON_0001295. ST Source(s): JCRB=JCRB1118; PubMed=25877200 ST Amelogenin: X ST CSF1PO: 9,10,13 ST D13S317: 11,12 ST D16S539: 8,10 ST D18S51: 12,13 ST D19S433: 14 ST D21S11: 27.2,29 ST D2S1338: 21,23 ST D3S1358: 16,17 ST D5S818: 13,14,15 ST D7S820: 8,9,11,12 ST D8S1179: 9,10,12 ST FGA: 20,21,22 ST Penta D: 10 ST Penta E: 14,15,17 ST TH01: 6,9,10 (JCRB=JCRB1118) ST TH01: 6,10 (PubMed=25877200) ST TPOX: 8,9,10 ST vWA: 16,18 (PubMed=25877200) ST vWA: 16,18,19 (JCRB=JCRB1118) DI NCIt; C6290; Endometrial endometrioid adenocarcinoma, variant with squamous differentiation OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 48Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 32 // RX PubMed=862644; DOI=10.1016/0014-2964(77)90213-4; RA Kuramoto, Hiroyuki RA Hamano, Mieko RT "Establishment and characterization of the cell-line of a human RT endometrial adenoacanthoma."; RL Eur. J. Cancer 13:253-259(1977). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254; RA Nusinow, David Paul RA Szpyt, John RA Ghandi, Mahmoud RA Rose, Christopher M. RA McDonald, E. Robert 3rd RA Kalocsay, Marian RA Jane-Valbuena, Judit RA Gelfand, Ellen T. RA Schweppe, Devin K. RA Jedrychowski, Mark P. RA Golji, Javad RA Porter, Dale A. RA Rejtar, Tomas RA Wang, Y. Karen RA Kryukov, Gregory V. RA Stegmeier, Frank RA Erickson, Brian K. RA Garraway, Levi Alexander RA Sellers, William Raj RA Gygi, Steven P. RT "Quantitative proteomics of the Cancer Cell Line Encyclopedia."; RL Cell 180:387-402.e16(2020). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura E. RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX PubMed=15053063; RA Kamata, Yuko RA Watanabe, Junichi RA Hata, Hiroki RA Hamano, Mieko RA Kuramoto, Hiroyuki RT "Quantitative study on the correlation between p53 gene mutation and RT its expression in endometrial carcinoma cell lines."; RL Eur. J. Gynaecol. Oncol. 25:55-60(2004). // RX DOI=10.1007/978-4-431-53981-0_1; RA Kuramoto, Hiroyuki RA Hamano, Mieko RA Imai, Manami RA Fujisawa, Takesi RA Kamata, Yuko RA Arai, Tsutomu RA Kawaguchi, Miwa RT "HEC-1 cells: establishment of an in vitro experimental system in RT endometrial carcinoma."; RL (In book chapter) Cell and molecular biology of endometrial carcinoma; Kuramoto, Hiroyuki & Nishida, Masato (eds.); pp.3-34; Springer; Tokyo; Japan (2003). // RX PubMed=2064198; DOI=10.1111/j.1749-6632.1991.tb37884.x; RA Kuramoto, Hiroyuki RA Nishida, Masato RA Morisawa, Takayuki RA Hamano, Mieko RA Hata, Hiroki RA Kato, Yoshiki RA Ohno, Eiji RA Iida, Tomohiro RT "Establishment and characterization of human endometrial cancer cell RT lines."; RL Ann. N. Y. Acad. Sci. 622:402-421(1991). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=10381137; DOI=10.1016/S0304-3835(98)00270-5; RA Ohta, Hiroho RA Sakamoto, Hideki RA Satoh, Kazuo RT "In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on RT cancer cell sensitivity to cis-platinum."; RL Cancer Lett. 134:111-118(1998). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, A. Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). //